Literature DB >> 15596037

Infection and anemia in Canadian aboriginal infants.

Noreen D Willows1, Katherine Gray-Donald.   

Abstract

The prevalence of anemia in Aboriginal children is high, but, given the high burden of infection in these children, the extent to which anemia is due to iron deficiency and/or infection is unclear. To determine the contribution of iron deficiency to anemia, we screened 144 Aboriginal infants (70 boys, 74 girls) who were free from infection. The prevalence of anemia (hemoglobin <105 g/L) was 18.8%; caregivers reported that 53.5% of infants had had an infection in the two weeks before screening. Anemic infants were more likely than non-anemic infants to have had an infection before screening (74.1% versus 48.7%, p = 0.02), and anemic infants had a higher prevalence of iron deficiency revealed by low serum iron concentrations (<7 micromol/L) (73.7% versus 38.3%, p <0.01). Iron deficiency measured using serum ferritin concentration tended to be less marked in infants who had had an infection (13% versus 30.3%, p = 0.06); this is probably because serum ferritin is a positive acute-phase protein. This study indicates the difficulty of isolating the contribution of infection to anemia from the separate effects of dietary iron deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596037     DOI: 10.3148/65.4.2004.180

Source DB:  PubMed          Journal:  Can J Diet Pract Res        ISSN: 1486-3847            Impact factor:   0.940


  3 in total

1.  Prevalence of anemia among Quebec Cree infants from 2002 to 2007 compared with 1995 to 2000.

Authors:  Noreen Willows; David Dannenbaum; Sophie Vadeboncoeur
Journal:  Can Fam Physician       Date:  2012-02       Impact factor: 3.275

Review 2.  Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations.

Authors:  K J Goodman; K Jacobson; S Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

3.  Iron deficiency and susceptibility to infections: evaluation of the clinical evidence.

Authors:  G S Tansarli; D E Karageorgopoulos; A Kapaskelis; I Gkegkes; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.